«This is expected to be the first of many new innovative therapies made possible by the Wyss Institute's collaborative
model of translational research that will enter human clinical trials,» said Wyss Founding Director Don Ingber, M.D., Ph.D., who is also the Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children's Hospital, and a Professor of Bioengineering at Harvard SEAS.
The effort is the fruit of a new
model of translational research being pursued at the Wyss Institute for Biologically Inspired Engineering at Harvard University that integrates the latest cancer research with bioinspired technology development.
Not exact matches
In 2015, Noebels and Dr. Isamu Aiba, a
research fellow in neurology at Baylor, published a paper in Science
Translational Medicine in which they described in a mouse
model what would happen if spreading depolarization, the blackout
of brain activity, occurred deep in the brainstem, which controls the heart beat and breathing.
His
research efforts are divided between preclinical
models, the development, performance, and monitoring
of cancer immunotherapy trials and the training
of the next generation
of translational investigators.
The journal's home page explains that
translational medicine «builds on basic
research advances — studies
of biological processes using cell cultures, for example, or animal
models — and uses them to develop new therapies or medical procedures.»
«
Modeling the process
of translational science, it is clear that greater emphasis needs to be placed on expediting the growth
of basic biomedical
research to improve the efficiency, timelines, and cost
of bringing new cures to market.»
«It's a dramatic increase in lifespan
of animal
models, as much as 25 percent,» said Leyuan Liu, PhD, assistant professor at the Texas A&M Institute
of Biosciences and Technology's Center for
Translational Cancer
Research.
«This study shows how
translational research using basic science techniques in animal
models can elucidate the underlying basis
of human emotions and reasons for mental disorders, thereby pointing the way for treatment development,» says Jeffrey Lieberman, MD, Lawrence C. Kolb Professor and Chair
of Psychiatry at CUIMC.
We carry out
translational research programmes to develop infectious disease vaccines, therapeutics and diagnostics using animal
models of tuberculosis, influenza, HIV / AIDS, Clostridium difficile, meningococcal disease, chlamydia, burkholderia and anthrax, as well as emerging viral diseases such as Crimean Congo haemorrhagic fever.
Additionally, the Institute's recent alliance with the California Institute for Biomedical
Research (Calibr) adds translational research to its capabilities, enabling a new bench - to - bedside model that will accelerate the translation of basic scientific discoveries into critically - needed new medicines for unmet medica
Research (Calibr) adds
translational research to its capabilities, enabling a new bench - to - bedside model that will accelerate the translation of basic scientific discoveries into critically - needed new medicines for unmet medica
research to its capabilities, enabling a new bench - to - bedside
model that will accelerate the translation
of basic scientific discoveries into critically - needed new medicines for unmet medical needs.
Models of interinstitutional partnerships between
research - intensive universities and minority serving institutions (MSI) across the Clinical
Translational Science Award (CTSA) Consortium.
These
models are used for both basic and
translational research, including studies to investigate the role
of tumor initiating cells in tumor relapse, tumor metastasis and therapy resistance.
This
research was supported by the NIH (R01 AR062368, R01 AR062920 to A.J.G and R01 DK055679, R01 DK059888, DK055679, DK059888, and DK089763 to A.N.), and J.R.S. is supported by the Intestinal Stem Cell Consortium (U01DK103141), a collaborative research project funded by the National Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious Diseases (NIAID), and by the NIAID Novel, Alternative Model Systems for Enteric Diseases (NAMSED) consortium (U19AI116482), PHS Grant UL1TR000454 from the Clinical and Translational Science Award Program, and a seed grant from the Regenerative Engineering and Medicine Research Center between Emory University, Georgia Tech and the University of
research was supported by the NIH (R01 AR062368, R01 AR062920 to A.J.G and R01 DK055679, R01 DK059888, DK055679, DK059888, and DK089763 to A.N.), and J.R.S. is supported by the Intestinal Stem Cell Consortium (U01DK103141), a collaborative
research project funded by the National Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious Diseases (NIAID), and by the NIAID Novel, Alternative Model Systems for Enteric Diseases (NAMSED) consortium (U19AI116482), PHS Grant UL1TR000454 from the Clinical and Translational Science Award Program, and a seed grant from the Regenerative Engineering and Medicine Research Center between Emory University, Georgia Tech and the University of
research project funded by the National Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute
of Allergy and Infectious Diseases (NIAID), and by the NIAID Novel, Alternative
Model Systems for Enteric Diseases (NAMSED) consortium (U19AI116482), PHS Grant UL1TR000454 from the Clinical and
Translational Science Award Program, and a seed grant from the Regenerative Engineering and Medicine
Research Center between Emory University, Georgia Tech and the University of
Research Center between Emory University, Georgia Tech and the University
of Georgia.
The ITCMS program, in its 41st year, was established to provide postdoctoral fellows an interdisciplinary training experience, including basic and
translational research opportunities with renowned investigators, and an extensive scope
of workshops and training modules with an emphasis on cancer
model systems.
Appropriate animal
models and
translational research to study sex differences are needed to get more insight into the pathophysiology and complex interplay
of hormones, genes, lifestyle, and environment.
The Center for Predictive Medicine recognizes the challenges
of translational research such as in designing and implementing high - throughput screens and assessing small molecules and potential vaccines for their efficacy in small animal
models of disease.
The role
of αCaMKII autophosphorylation in the establishment
of alcohol addiction Alanna Easton, King's College, UK Novel age - dependent learning deficits in a mouse
model of Alzheimer's disease: implications for
translational research Karienn Montgomery, University
of Florida, USA Microsatellite regions upstream
of the vole Avpr1a gene contribute to both individual and species differences in receptor expression Zoe Donaldson, Columbia University, USA Per Genes and Addiction Stephanie Perreau - Lenz, Central Institute
of Mental Health, Germany
Topics covered include embryonic stem cells, pluripotency, germline stem cells, tissue - specific stem cells, stem cell differentiation, epigenetics, stem cell genomics and systems biology, genome reprogramming, cancer stem cells, stem cell niches, stem - cell - based disease
models, nuclear transfer technology, bioengineering, drug discovery, in vivo imaging
of stem cells, therapeutic applications, regenerative medicine, clinical and
translational insights, stem cell
research policies, ethical issues, and technical or resource - based innovations.
Researchers at the National Institute
of Neurological Disorders and Stroke and the National Institutes
of Health recently designated SMA as a
model for
translational research funding, which uses basic scientific
research to devise actual drugs and treatments.
Dr. Falk is also PI
of an NIH, pharma, and philanthropic funded
translational research laboratory group at CHOP that investigates the causes and global metabolic consequences
of mitochondrial disease, as well as targeted therapies, in C. elegans, zebrafish, mouse, and human tissue
models of genetic - based respiratory chain dysfunction, and directs multiple clinical treatment trials in mitochondrial disease patients.
The National Institute
of Neurological Disease and Stroke recently designated spinal muscular atrophy as the
model for its new approach to funding «
translational research.»
She is the Principle Investigator
of the I - SPY TRIAL program, a multi-site neoadjuvant clinical trial (which includes phase 2 and 3 trials) that has evolved into a
model for
translational research and innovation in clinical trial design.
The ITCMS postdoctoral training program at the UNC Lineberger Comprehensive Cancer Center provides an exceptional interdisciplinary training experience, including outstanding basic and
translational research opportunities with renowned investigators, and an extensive scope
of workshops and training modules with an emphasis on cancer
model systems.
Oncology investigators in the NC State Center for Comparative Medicine and
Translational Research, for example, focus on understanding the pathogenesis and treatment
of cancer through studies involving, in part, spontaneous
models of cancer provided by Terry Center oncology patients.
My lab is is a
research unit
of the Department
of Surgery located on the veterinary hospital campus, primarily focused on
translational research using complex nonhuman primate (NHP) disease
models and screening rodent
models.
Supporting high - value, contemporary, best practice care: enhanced funding for
translational research; quality improvement measures across the health system; a longer term, more sustained
model of MBS review.